Coherus Biosciences | L'Utile Ante Imposte

Prezzo Delle Azioni
2.15
Cambio Giornaliero
0.09 4.13%
Mensile
30.00%
Annuale
93.24%
Q1 Previsione
2.39




L'Utile Ante Imposte Cambiamento Data
AbbVie USD 4.38B 1.92B 2025-09
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Akebia Therapeutics USD 6.11M 28.92M 2025-03
ALKERMES USD 100.74M 4.1M 2025-09
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Amarin USD -8.12M 5.34M 2025-09
Amgen USD 3.92B 2.35B 2025-09
Baxter International USD 121M 12M 2025-09
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Coherus Biosciences USD -47.4M 14.9M 2025-03
Eli Lilly USD 7.23B 456M 2025-09
Fujifilm JPY 100.28B 10.32B 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
Merck USD 6.74B 22M 2025-09
Myriad Genetics USD 6.2M 2.1M 2024-12
Pacira USD -1.93M 10.63M 2025-06
Perrigo USD 22.4M 19.2M 2025-09
Pfizer USD 3.33B 290M 2025-09
PTC Therapeutics USD -23.07M 47.98M 2025-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
Teva Pharmaceutical Industries USD 91M 555M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Xencor USD -6.03M 25.05M 2025-09
Zoetis USD 887M 15M 2025-09


Coherus Biosciences L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.